COVID-19
Conditions
Brief summary
The aim of this work is to estimate the frequency of small airway disease and/or the bronchial hyperreactivity in follow up of postacute covid survivors.
Detailed description
This is a observational longitudinal study investigating pulmonary sequelae of covid-19. Study site: Mansoura university hospital, chest department and post covid outpatient clinic. Elmahalla chest hospital and outpatients clinic. Time of study : Two years from September 2021 to September 2023 Target population: Adults with confirmed covid 19 who remaining symptomatic after 30 days from the diagnosis. Sample size The study will include 100 selected cases during period from 2021 to 2023 Patients : The enrolled patients are adults who survived acute covid-19 and presented for clinical follow up.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Ambulatory adult patients confirmed diagnosis of covid -19 either on typical CT chest basis or PCR and passed period of acute illness (28 days from start of symptoms) but still with clinical symptoms.
Exclusion criteria
* Hospitalized or requiring intensive care unit. Known patients with chronic lung diseases Uncontrolled comorbidities
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| investigating pulmonary sequelae of covid-19. | 3moth | The selected post covid patients on the day of their clinic visit (one to three months after being diagnosed covid 19 |
Countries
Egypt